Great Minds Think Similarly: The Pros and Cons of Biosimilars
Ever wish you could replicate the taste of that $200 bottle of wine that has been aged to perfection over the past four decades? This task is a near impossibility, as it requires y
It’s like Finding Money: Repurposing Content Marketing
Being very deliberate about creating specific content based on a buyer’s journey, and then distributing said content, might not necessarily be part of your marketing mix. Content
Choose Your Own Marketing Adventure in “Marketing Survival”
Don’t you wish that you could simply get a 2nd chance on some of your life science marketing decisions? There are so many advertising options out there for marketers, and choosin
What You Cared About in 2017
This past year was filled with just as many “Woah, that’s awesome” moments as “Wait, is this actually happening?” ones. Through all of the commotion of 2017, Chemunity wa
Healthcare Game-Changers: Innovations Shaping the Industry
In an industry that develops as quickly as healthcare, it’s difficult to know which innovations will lead to lasting change and which will be promptly replaced by the next exciti
Selecting the Right Investment Bank to Take Your Company Public
Taking a company public is a momentous milestone in the growth of a life science or healthcare company. Whether or not an initial public offering (IPO) is in your company’s futur
iBIO IndEx 2017: Amid Political Uncertainty, Industry Collaboration Is Key to Advancement
The effects of technological advances and an uncertain political environment were the focus of this year’s Illinois Biotechnology Innovation Organization (iBIO) Industry Expo (In
Europe to Issue New Safety Regulations for Medical Devices and Diagnostics: What You Need to Know
Want to find a place in the EU market for your IVD/med device? You’ll need to get through some new hoops first! As the first quarter of 2017 drew to a close, the in vitro diagnos
Gene Editing with CRISPR Technology: Keeping the Focus on Patients
Ever since a proof-of-concept paper was published in 2012, the gene-editing technique CRISPR-Cas9 has been making waves as a major scientific breakthrough—one that has captured t